MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Net Income
-$9,937,000
EPS
-$0.17
Unit: Dollar
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
License revenue
0
0
0
0
Research and development
7,393,000
7,003,000
6,296,000
7,437,000
General and administrative
4,664,000
4,256,000
3,966,000
3,541,000
Impairment of right-of-use assets and property and equipment
-
-
7,348,000
-
Total operating expenses
12,057,000
11,259,000
17,610,000
10,978,000
Income (gain) from operations
-12,057,000
-11,259,000
-17,610,000
-10,978,000
Interest income
922,000
1,023,000
1,184,000
1,164,000
Other income (expense)
1,230,000
1,200,000
1,310,000
1,316,000
Total other income (expense), net
2,152,000
2,223,000
2,494,000
2,480,000
Net income (gain)
-9,905,000
-9,036,000
-15,116,000
-8,498,000
Unrealized loss (gain) on investments, net
-32,000
-137,000
-41,000
167,000
Comprehensive income (gain)
-9,937,000
-9,173,000
-15,157,000
-8,331,000
Basic EPS
-0.17
-0.16
-0.266
-0.15
Diluted EPS
-0.17
-0.16
-0.258
-0.15
Basic Average Shares
57,367,283
57,233,413
57,076,093
56,929,103
Diluted Average Shares
57,367,283
57,233,413
58,845,332
56,929,103
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Comprehensive income (gain)-$9,937,000 (5.96%↑ Y/Y)Other income(expense)$1,230,000 (-29.35%↓ Y/Y)Interest income$922,000 (-17.53%↓ Y/Y)Net income (gain)-$9,905,000 (6.21%↑ Y/Y)Unrealized loss (gain) oninvestments, net-$32,000 (-433.33%↓ Y/Y)Total other income(expense), net$2,152,000 (-24.73%↓ Y/Y)Income (gain) fromoperations-$12,057,000 (10.16%↑ Y/Y)Total operatingexpenses$12,057,000 (-10.16%↓ Y/Y)Research and development$7,393,000 (-20.67%↓ Y/Y)General andadministrative$4,664,000 (13.73%↑ Y/Y)

Black Diamond Therapeutics, Inc. (BDTX)

Black Diamond Therapeutics, Inc. (BDTX)